These effects appear to be related reductions in depression‐associated cytokines, such as tumor necrosis factor‐alpha (TNF‐α), interleukin‐18 (IL‐18), and IL‐6 (J. Wang et al., 2016). Here, IL18 is linked to depressive symptom measurement.